Related references
Note: Only part of the references are listed.Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer
Seoyul Lee et al.
Molecular Therapy-Oncolytics (2022)
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Kharimat Lora Alatise et al.
CANCERS (2022)
CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells
Shufeng Zhou et al.
CANCERS (2022)
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
Kristin Koerdel et al.
CANCERS (2021)
Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling
Kang-Yun Lee et al.
CELLS (2021)
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
Melayshia McFadden et al.
CANCERS (2021)
CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity
Pauliina Filppu et al.
JCI INSIGHT (2021)
Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling
Kang-Yun Lee et al.
CANCER SCIENCE (2020)
CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells
Yuuri Hatsuzawa et al.
PANCREATOLOGY (2020)
CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma
Xue-Tang Mo et al.
BRITISH JOURNAL OF CANCER (2020)
CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling
Tetsuro Taki et al.
CANCER SCIENCE (2020)
Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells
Xue-qian Qian et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation
Mutsuko Minata et al.
CELL REPORTS (2019)
Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
Walhan Alshaer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis
Shinji Mii et al.
PATHOLOGY INTERNATIONAL (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
So Young Kim et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2019)
Significance of perivascular tumour cells defined by CD109 expression in progression of glioma
Yukihiro Shiraki et al.
JOURNAL OF PATHOLOGY (2017)
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis
Chen-Hua Chuang et al.
NATURE MEDICINE (2017)
HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
Lei Sun et al.
JOURNAL OF CANCER (2017)
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
Hes1: a key role in stemness, metastasis and multidrug resistance
Zi-Hao Liu et al.
CANCER BIOLOGY & THERAPY (2015)
The role of ABC transporters in ovarian cancer progression and chemoresistance
M. P. Ween et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway
M. T. Weng et al.
PLOS ONE (2015)
SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC
Fanglin Zhang et al.
JOURNAL OF PROTEOMICS (2014)
CD109 is a potential target for triple-negative breast cancer
Ji Tao et al.
TUMOR BIOLOGY (2014)
Ovarian cancer stem cells: Working towards the root of sternness
Rosemary Foster et al.
CANCER LETTERS (2013)
mTOR inhibitor RAD001 (everolimus) induces apoptotic, not autophagic cell death, in human nasopharyngeal carcinoma cells
Yuchen Cai et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma
Makoto Emori et al.
PLOS ONE (2013)
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
Zhiwei Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
Treatment for Recurrent Ovarian Cancer-At First Relapse
Kimio Ushijima
JOURNAL OF ONCOLOGY (2010)
Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes
Ashok Agarwal et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling
S Kamakura et al.
NATURE CELL BIOLOGY (2004)
Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins
M Lin et al.
BLOOD (2002)
Share Paper
